CLINICAL_TRIALS
trial_result
· 2013-09-02
Clinical Trial Update: Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units [NA]
Summary
Clinical trial evaluating a 4mm x 32G pen needle for higher basal insulin doses in type 2 diabetes was terminated; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Becton, Dickinson and Company | Conditions: Diabetes Mellitus, Type 2 | NA | Status: TERMINATED | Results posted: 2013-09-02